FindTrial
Sign In

Retrospective multicenter study for comparison of two surgical techniques (LAP vs. LSK) as therapy of early-staged ovarian cancer and borderline-tumor of the ovaries in regards to intra- and postoperative complications, oncological outcome and fertility preservation.

Retrospective multicenter study for comparison of two surgical techniques (LAP vs. LSK) as therapy of early-staged ovarian cancer and borderline-tumor of the ovaries in regards to intra- and postoperative complications, oncological outcome and fertility preservation.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00013084
Enrollment
120
Registered
2018-04-26
Start date
2017-10-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C56

Interventions

Group 1: Minimally-invasive surgery at malignant neoplasms of the ovaries. Retrospective data assesment and analysation of surgical parameters and follow-up Data out of digitalized and archived patien

Sponsors

Universitätsklinikum des Saarlandes
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Included are all patients who got surgical treatment for early-staged malignant neoplasms of the ovaries and borderline-tumors of the ovaries at University Medical Center Homburg/Saar from 01/1998 to 07/2017. Furthermore, in a second step, all patients with similar criteria, who got surgical treatment in one of our cooperating medical centers are included. Early-staged tumors are T1 and T2 stage tumors. Subsequently the patients will be separated in two groups: laparoscopic treatments versus open surgical treatment via abdominal incision.

Exclusion criteria

Exclusion criteria: 1. Laparoscopy because of benign neoplasms of the ovaries. 2. Minimally-invasiv surgery at advanced ovarial carcinoma. 3. Incomplete data.

Design outcomes

Primary

MeasureTime frame
The primary endpoints are the relapse-free survival and the overall survival of the patients. Therefore a Follow-Up off all included patients will be made. On the one hand this will be achived through retrospective data research and on the other hand through communication with the patients. Women who underwent surgical treatment recently (2017) will be followed-up prospectively over a period of approximately 10 years in addition.—

Secondary

MeasureTime frame
Secondary endpoints are the surgical outcome like surgery time, blood loss, intra- and postoperative complications and postoperative hospital stay. In women who got fertility-conserving surgery the fertility will also be a secondary endpoint. These parameters will be collected via data research out of digitized and archived medical records.—

Countries

Germany

Contacts

Public ContactJulia Radosa

Universitätsfrauenklinik Homburg

julia.radosa@uks.eu068411628101

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026